Zymeworks, Inc. (ZYME)
23.15
-0.02
(-0.09%)
USD |
NASDAQ |
Jan 12, 16:00
23.49
+0.34
(+1.47%)
After-Hours: 19:55
Zymeworks Research and Development Expense (Quarterly): 35.58M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Jazz Pharmaceuticals Plc | 198.20M |
| Johnson & Johnson | 3.693B |
| Regeneron Pharmaceuticals, Inc. | 1.338B |
| Vertex Pharmaceuticals, Inc. | 977.70M |
| CorMedix, Inc. | 5.098M |